Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Broad familiarity among endocrinologists and primary care physicians carried over from type 2 diabetes care continues to reinforce its clinical dominance
Clarifying treatment goals with your healthcare provider ensures that progress is measured appropriately and that expectations align with clinical evidence
For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with improved long-term graft survival and overall survival, according to study data
Its standard of care in many settings
Compared to the liver, we observed that the kidney has: (1) similar increased use of energy-related metabolites and production of urea cycle and ammonia-related intermediates, suggesting a shared catabolism in AKI, and (2) higher pools of energy metabolism intermediates in AKI
13 Regarding the application of GLP-1RAs in MASLD, current understanding suggests they can serve as additional pharmaceutical options in lifestyle management for patients with complications like obesity and T2DM
US$ 20.04
US$ 25.06
US$ 26.80
US$ 29.49
US$ 25.08
